(LOGC) Logicbio Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Logicbio Therapeutics | (LOGC) share price targets
Complete technical analysis of Logicbio Therapeutics (LOGC) by charts plus indicators, forecast predictions and share price targets for Logicbio Therapeutics (LOGC)
Logicbio Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Logicbio Therapeutics is 344260
| Date | Daily Closing Price | Open | High | Low | Volume |
| 09 Wed Apr 2025 | 6.91 | 6.34 | 6.98 | 6.34 | 1.027 times |
| 08 Tue Apr 2025 | 6.39 | 6.64 | 6.66 | 6.30 | 0.878 times |
| 07 Mon Apr 2025 | 6.48 | 6.30 | 6.72 | 6.15 | 1.1 times |
| 04 Fri Apr 2025 | 6.47 | 6.70 | 6.83 | 6.30 | 1.436 times |
| 03 Thu Apr 2025 | 6.89 | 6.82 | 7.04 | 6.76 | 1.584 times |
| 02 Wed Apr 2025 | 7.14 | 6.87 | 7.40 | 6.87 | 0.759 times |
| 01 Tue Apr 2025 | 6.91 | 6.99 | 7.14 | 6.86 | 0.785 times |
| 31 Mon Mar 2025 | 6.98 | 6.77 | 7.08 | 6.76 | 0.749 times |
| 28 Fri Mar 2025 | 6.95 | 7.07 | 7.16 | 6.85 | 0.966 times |
| 24 Mon Mar 2025 | 7.51 | 7.57 | 7.62 | 7.44 | 0.553 times |
My analysis of stock is bearish for shortterm, and stock might move down till 6.7 or till 6.3. Use a stoploss of 7.11 and if the stock hits stoploss, then it can shoot up till 7.49
Share price targets for Logicbio Therapeutics (LOGC)
| Target Type | Value |
| Downside Target | 6.15 |
| Downside Target | 6.29 |
| Downside Target | 6.43 |
| Downside Target | 6.65 |
| Downside Target | 6.85 |
| Upside Target | 7.19 |
| Upside Target | 7.40 |
| Upside Target | 7.61 |
| Upside Target | 7.62 |
| Upside Target | 7.73 |
| Upside Target | 7.80 |
| Upside Target | 8.21 |
| Upside Target | 8.38 |
| Upside Target | 9.34 |
Intraday share price targets for Logicbio Therapeutics (LOGC)
| Target Type | Value |
| Downside Intraday Target | 6.38 |
| Downside Intraday Target | 5.85 |
| Upside Intraday Target | 7.21 |
| Upside Intraday Target | 7.51 |
| Downside Intraday Target | 6.68 |
Weekly technical analysis of Logicbio Therapeutics (LOGC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 09 Wed Apr 2025 | 6.91 | 6.30 | 6.98 | 6.15 | 0.566 times |
| 04 Fri Apr 2025 | 6.47 | 6.77 | 7.40 | 6.30 | 3.497 times |
| 28 Fri Mar 2025 | 6.95 | 7.57 | 7.62 | 6.85 | 0.341 times |
| 21 Fri Mar 2025 | 7.52 | 7.55 | 7.73 | 7.19 | 0.689 times |
| 14 Fri Mar 2025 | 7.55 | 7.20 | 7.61 | 6.65 | 0.853 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Logicbio Therapeutics (LOGC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 09 Wed Apr 2025 | 6.91 | 6.99 | 7.40 | 6.15 | 0.365 times |
| 31 Mon Mar 2025 | 6.98 | 8.29 | 8.38 | 6.65 | 1.151 times |
| 28 Fri Feb 2025 | 8.19 | 7.60 | 9.34 | 7.21 | 1.672 times |
| 31 Fri Jan 2025 | 7.77 | 7.08 | 7.80 | 6.29 | 0.99 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Logicbio Therapeutics (LOGC)
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Logicbio Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Logicbio Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Logicbio Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Logicbio Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Logicbio Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.81 and Logicbio Therapeutics (LOGC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Logicbio Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Logicbio Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Logicbio Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Logicbio Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Logicbio Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.81 and Logicbio Therapeutics (LOGC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.